Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 101-111, January 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Redman, C. M.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Redman, C. M.
Right arrow Articles by Morris, H. P.

In Vitro Synthesis and Secretion of Albumin by Morris Hepatomas 5123C and 78001

C. M. Redman2, S. Yu, D. Banerjee and H. P. Morris

Lindsley F. Kimball Research Institute of the New York Blood Center, New York, New York 10021 [C. M. R., S. Y., D. B.], and Department of Biochemistry, Cancer Research Unit, College of Medicine, Howard University, Washington, D. C. 20059 [H. P. M.]

Morris hepatomas 5123C and 7800 were incubated in vitro with radioactive L-leucine in Krebs-Ringer-bicarbonate-saline, and the incorporation of radioactivity into albumin precursors, serum albumin, and trichloroacetic acid-precipitable proteins was measured and compared to that which occurs in normal rat liver slices. At the end of a 10-min pulse incubation with radioactive L-leucine, Morris hepatoma 7800 incorporated 0.25% of the total protein radioactivity into an albumin fraction while Morris Hepatoma 5123C incorporated 0.5% and rat liver slices showed a much larger proportion of incorporation (4.8%) into albumin. The pulse-labeled tissues were further incubated with nonradioactive L-leucine for different periods of time, and they all released radioactive proteins into the incubation medium. Only 5% of the total protein radioactivity released into the medium by Morris hepatoma 7800 and 7.8% of that released by Morris hepatoma 5123C were incorporated into albumin while, in contrast, rat liver slices released 46% of its protein radioactivity as albumin. Both hepatomas were capable of releasing 80% of the pulse-labeled albumin into the medium at the end of a 75-min chase period. Analyses of the nascent albumin within the tissues of Morris hepatomas 7800 and 5123C and in rat liver slices showed that, at the end of a 10-min pulse incubation, the intracellular albumin fraction could be identified as a precursor of serum albumin (proalbumin) and that, as the chase incubation proceeded, proalbumin was converted intracellularly to another form of albumin which was chromatographically distinct from serum albumin. The radioactive albumin which was released into the medium, however, closely resembled serum albumin. Like normal liver, Morris hepatomas 5123C and 7800 are able to segregate nascent proalbumin in the microsomal cell fraction, and only a small amount (8%) was found in the soluble cytoplasmic fraction. Also like normal liver, a messenger RNA fraction isolated from Morris hepatoma 7800 can be translated by an in vitro protein-synthesizing system into a larger albumin precursor containing L-leucine in positions 7, 8, 9, and 10. These studies indicate that Morris hepatomas 5123C and 7800, while synthesizing smaller amounts of albumin than does normal liver are, however, capable of normal processing of precursor into serum albumin and appear to secrete serum albumin into the incubation medium.

1 Supported by USPHS Grants AM20888 and HL09011, and in part by Grant CA 10729.

2 To whom requests for reprints should be addressed.

Received 6/29/78. Accepted 10/ 3/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.